Wingerd M, Bernhard V M, Maddison F, Towne J B
Arch Surg. 1978 Nov;113(11):1264-71. doi: 10.1001/archsurg.1978.01370230054006.
Over a seven-year period, 38 Mobin-Uddin MU and 33 Kim-Ray Greenfield KG vena cava filters were inserted in 71 patients with no substantial complications or deaths directly related to the surgical procedure. Thirteen of the 16 early deaths were due to progression of associated diseases. The remaining three deaths were caused by pulmonary emboli and occurred in each instance after insertion of a MU filter. None of the 14 late deaths were related to the caval filter or sequellae of venous thrombosis. Inferior vena cava patency was objectively assessed in 36 patients by cavagram (22) or autopsy (14). Caval patency of 95% (18 of 19) in those with KG filters was significantly greater than the 47% patency (eight of 17) seen with MU devices (P less than .01). Gray scale ultrasound, when successful in visualizing the vena cava, was found to be a reliable indicator of patency. Venous stasis phenomena were noted in 50% of those with a patent cava and in 70% of those with an occlusion. Thus, it is not surprising that edema was found in only 38% of the patients as compared with 75% of the patients with the MU filter. Both of these devices are safe to insert. However, on the basis of superior patency rate, lower incidence of stasis phenomena, and the absence of recurrent pulmonary emboli in our series, we prefer insertion of a KG filter when caval interruption is required.
在七年的时间里,为71例患者植入了38个莫宾-乌丁(Mobin-Uddin,MU)腔静脉滤器和33个金-雷格林菲尔德(Kim-Ray Greenfield,KG)腔静脉滤器,没有发生与手术操作直接相关的严重并发症或死亡。16例早期死亡中有13例是由相关疾病进展所致。其余3例死亡是由肺栓塞引起,均发生在植入MU滤器之后。14例晚期死亡均与腔静脉滤器或静脉血栓后遗症无关。通过腔静脉造影(22例)或尸检(14例)对36例患者的下腔静脉通畅情况进行了客观评估。植入KG滤器的患者下腔静脉通畅率为95%(19例中的18例),显著高于植入MU装置患者的47%通畅率(17例中的8例)(P小于0.01)。当能够成功显示腔静脉时,灰阶超声被发现是通畅情况的可靠指标。在下腔静脉通畅的患者中,50%出现了静脉淤滞现象,而在下腔静脉闭塞的患者中,这一比例为70%。因此,与植入MU滤器的患者中75%出现水肿相比,仅38%的患者出现水肿也就不足为奇了。这两种装置植入时都是安全的。然而,基于我们系列研究中更高的通畅率、更低的淤滞现象发生率以及无复发性肺栓塞,当需要中断下腔静脉时,我们更倾向于植入KG滤器。